Atlas Trials

Long Term Cardio-Vascular Risk Assessment in CKD and Kidney Transplanted Patients Following SARS-COV-2

Clinical trial NCT05125913 · UNKNOWN

Trial details

NCT number
NCT05125913
Sponsor
Grigore T. Popa University of Medicine and Pharmacy
Status
UNKNOWN
Study type
OBSERVATIONAL
CKDDialysisKidney TransplantCOVID-19Cardiovascular DiseaseEndothelial Dysfunction
Start date
2021-01-04
Primary completion
2023-12-31
Enrollment
250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.